Market Dynamics:

The medical nutrition market is witnessing significant growth owing to the rising prevalence of malnutrition across the globe. Malnutrition refers to deficiencies, excesses, or imbalances in a person's intake of energy and/or nutrients. It encompasses different conditions, from undernutrition to overnutrition. According to data by the World Health Organization, nearly 45% of deaths among children under-5 years of age are linked to undernutrition. It is a major factor affecting public health globally. Furthermore, changing lifestyles and busy schedules have disrupted dietary habits, contributing to rising incidence of malnutrition. This has augmented the demand for medical nutrition products for treating deficiency-related disorders. Another driver for the medical nutrition market is the increasing geriatric population worldwide. Older adults are more prone to malnutrition due to aging related illness, reduced appetite, and decreased mobility. This age group has greater nutritional requirements, fueling adoption of dietary supplements and therapeutic formulas.

SWOT Analysis

Strength: The medical nutrition market has high opportunities for growth due to the rising prevalence of chronic diseases globally. Moreover, increasing adoption of nutritional supplements to boost immunity and a growing number of nutrition-based clinical trials have been boosting market growth. Rising awareness among physicians and patients regarding medical nutrition is also driving the market.

Weakness: However, lack of awareness in some developing regions and higher costs of clinically-tested medical nutrition products in comparison to grocery food items are restraining market growth. Also, lack of nutritional screening and nutritional guidelines pose challenges.

Opportunity: Rising healthcare expenditure across developing regions is expected to create new opportunities. Growing geriatric population susceptible to chronic diseases also provides new avenues. Furthermore, innovations enabling personalized nutrition based on patients' genetics, epigenetics and gut microbiomes can expand growth prospects.

Threats: Stringent regulatory framework and lack of reimbursement policies in some countries can hamper market revenues. Threats from related alternative therapies and economic slowdowns impacting discretionary spends also act as challenges.

Key Takeaways

The Global Medical Nutrition Market Size  is expected to witness high growth. The market size was valued at US$ 16.52 Mn in 2024 and is expected to grow at a CAGR of 5.1% during the forecast period to reach US$ 22.39 Mn by 2031.

Regional analysis comprises:
North America will continue dominating the market due to growing obesity and related chronic diseases. Favorable reimbursement policies are also supporting growth. However, Asia Pacific is poised to grow at the fastest pace during the forecast period. This is attributed to improving access to healthcare services, rising incomes, expanding medical tourism industry and increasing investment by market players looking to tap opportunities.

Key players related content comprises:
Key players operating in the medical nutrition market include Aprea Therapeutics, Novartis AG, Rocket Pharmaceuticals, Inc., GeneDx, BioMarin Pharmaceutical Inc., AbbVie Inc., Bristol Myers Squibb, Pfizer Inc., Vertex Pharmaceuticals Incorporated, CRISPR Therapeutics, Editas Medicine, Fate Therapeutics, Inc., Regenxbio Inc., Orchard Therapeutics, uniQure N.V. These players are focusing on new product development and commercialization strategies to strengthen their positions in the market.

Explore more information on this topic, Please visit-   
https://www.pressreleasebulletin.com/medical-nutrition-market-size-and-share-analysis-growth-trends-and-forecasts/